Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Eur J Med Chem. 2013 Jan 11;62:40–50. doi: 10.1016/j.ejmech.2013.01.006

Table 2.

Inhibition of tubulin polymerization and colchicine binding by 129.

Comp. No. Tubulin polymerization inhibition
Inhibition of colchicine binding (% ± SD)
IC50 (μM ± SD) 50 μM 5 μM
1 2.9 ± 0.3 39 ± 5 24 ± 0.8
2 5.2 ± 0.2 38 ± 1 9.3 ± 3
3 6.5 ± 0.08 14 ± 5 7.0 ± 4
4 >20 / /
5 >20 / /
6 9.7 ± 1 25 ± 2 3.1 ± 3
7 >20 / /
8 11 ± 2 14 ± 0.8 9.6 ± 5
9 8 ± 0.08 19 ± 4 12 ± 0.01
10 >20 / /
11 >20 / /
12 >20 / /
13 >20 / /
14 >20 / /
15 >20 / /
16 >20 / /
17 11 ± 0.07 13 ± 2 8.9 ± 2
18 >20 / /
19 >20 / /
20 18 ± 0.9 / /
21 11 ± 0.1 20 ± 5 2.7 ± 4
22 >20 / /
23 3.5 ± 0.3 31 ± 4 11 ± 3
24 11 ± 0.6 19 ± 0.8 2.8 ± 1
25 10 ± 2 20 ± 5 0.3 ± 2
26 8.6 ± 0.5 28 ± 4 6.2 ± 3
27 7.8 ± 1 24 ± 2 5.9 ± 5
28 >20 / /
29 >20 / /
Combretastatin A-4 1.2 ± 0.007 / 99 ± 0.7